These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 25566730

  • 21. Bone strength and muscle properties in postmenopausal women with and without a recent distal radius fracture.
    Crockett K, Arnold CM, Farthing JP, Chilibeck PD, Johnston JD, Bath B, Baxter-Jones AD, Kontulainen SA.
    Osteoporos Int; 2015 Oct; 26(10):2461-9. PubMed ID: 26001559
    [Abstract] [Full Text] [Related]

  • 22. Effects of oral alendronate and intranasal salmon calcitonin on bone mass and biochemical markers of bone turnover in postmenopausal women with osteoporosis.
    Adami S, Passeri M, Ortolani S, Broggini M, Carratelli L, Caruso I, Gandolini G, Gnessi L, Laurenzi M, Lombardi A.
    Bone; 1995 Oct; 17(4):383-90. PubMed ID: 8573412
    [Abstract] [Full Text] [Related]

  • 23. Intranasal salmon calcitonin for the prevention and treatment of postmenopausal osteoporosis.
    Ellerington MC, Hillard TC, Whitcroft SI, Marsh MS, Lees B, Banks LM, Whitehead MI, Stevenson JC.
    Calcif Tissue Int; 1996 Jul; 59(1):6-11. PubMed ID: 8661976
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study).
    Tsai JN, Uihlein AV, Burnett-Bowie SM, Neer RM, Derrico NP, Lee H, Bouxsein ML, Leder BZ.
    J Clin Endocrinol Metab; 2016 May; 101(5):2023-30. PubMed ID: 26964731
    [Abstract] [Full Text] [Related]

  • 26. Bone density, turnover, and estimated strength in postmenopausal women treated with odanacatib: a randomized trial.
    Brixen K, Chapurlat R, Cheung AM, Keaveny TM, Fuerst T, Engelke K, Recker R, Dardzinski B, Verbruggen N, Ather S, Rosenberg E, de Papp AE.
    J Clin Endocrinol Metab; 2013 Feb; 98(2):571-80. PubMed ID: 23337728
    [Abstract] [Full Text] [Related]

  • 27. Effect of 12 months of whole-body vibration therapy on bone density and structure in postmenopausal women: a randomized trial.
    Slatkovska L, Alibhai SM, Beyene J, Hu H, Demaras A, Cheung AM.
    Ann Intern Med; 2011 Nov 15; 155(10):668-79, W205. PubMed ID: 22084333
    [Abstract] [Full Text] [Related]

  • 28. Characterizing microarchitectural changes at the distal radius and tibia in postmenopausal women using HR-pQCT.
    Kawalilak CE, Johnston JD, Olszynski WP, Kontulainen SA.
    Osteoporos Int; 2014 Aug 15; 25(8):2057-66. PubMed ID: 24781379
    [Abstract] [Full Text] [Related]

  • 29. Postmenopausal women with osteopenia have higher cortical porosity and thinner cortices at the distal radius and tibia than women with normal aBMD: an in vivo HR-pQCT study.
    Nishiyama KK, Macdonald HM, Buie HR, Hanley DA, Boyd SK.
    J Bone Miner Res; 2010 Apr 15; 25(4):882-90. PubMed ID: 19839766
    [Abstract] [Full Text] [Related]

  • 30. In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography.
    Boutroy S, Bouxsein ML, Munoz F, Delmas PD.
    J Clin Endocrinol Metab; 2005 Dec 15; 90(12):6508-15. PubMed ID: 16189253
    [Abstract] [Full Text] [Related]

  • 31. Additive impact of alfacalcidol on bone mineral density and bone strength in alendronate treated postmenopausal women with reduced bone mass.
    Felsenberg D, Bock O, Börst H, Armbrecht G, Beller G, Degner C, Stephan-Oelkers M, Schacht E, Mazor Z, Hashimoto J, Roth HJ, Martus P, Runge M.
    J Musculoskelet Neuronal Interact; 2011 Mar 15; 11(1):34-45. PubMed ID: 21364273
    [Abstract] [Full Text] [Related]

  • 32. Effect of nasal salmon calcitonin on bone remodeling and bone mass in postmenopausal osteoporosis.
    Thamsborg G, Jensen JE, Kollerup G, Hauge EM, Melsen F, Sorensen OH.
    Bone; 1996 Feb 15; 18(2):207-12. PubMed ID: 8833216
    [Abstract] [Full Text] [Related]

  • 33. The effect of calcitonin on biochemical markers and zinc excretion in postmenopausal osteoporosis.
    Colpan L, Gur A, Cevik R, Nas K, Sarac AJ.
    Maturitas; 2005 Jul 16; 51(3):246-53. PubMed ID: 15978968
    [Abstract] [Full Text] [Related]

  • 34. Salmon calcitonin plus intravaginal estriol: an effective treatment for the menopause.
    Melis GB, Cagnacci A, Bruni V, Falsetti L, Jasonni VM, Nappi C, Polatti F, Volpe A.
    Maturitas; 1996 May 16; 24(1-2):83-90. PubMed ID: 8794438
    [Abstract] [Full Text] [Related]

  • 35. Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women.
    Downs RW, Bell NH, Ettinger MP, Walsh BW, Favus MJ, Mako B, Wang L, Smith ME, Gormley GJ, Melton ME.
    J Clin Endocrinol Metab; 2000 May 16; 85(5):1783-8. PubMed ID: 10843152
    [Abstract] [Full Text] [Related]

  • 36. Vitamin K2 (menaquinone-7) prevents age-related deterioration of trabecular bone microarchitecture at the tibia in postmenopausal women.
    Rønn SH, Harsløf T, Pedersen SB, Langdahl BL.
    Eur J Endocrinol; 2016 Dec 16; 175(6):541-549. PubMed ID: 27625301
    [Abstract] [Full Text] [Related]

  • 37. A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D.
    Henriksen K, Byrjalsen I, Andersen JR, Bihlet AR, Russo LA, Alexandersen P, Valter I, Qvist P, Lau E, Riis BJ, Christiansen C, Karsdal MA, SMC021 investigators.
    Bone; 2016 Oct 16; 91():122-9. PubMed ID: 27462009
    [Abstract] [Full Text] [Related]

  • 38. Effect of oral monthly ibandronate on bone microarchitecture in women with osteopenia-a randomized placebo-controlled trial.
    Chapurlat RD, Laroche M, Thomas T, Rouanet S, Delmas PD, de Vernejoul MC.
    Osteoporos Int; 2013 Jan 16; 24(1):311-20. PubMed ID: 22402673
    [Abstract] [Full Text] [Related]

  • 39. Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitonin.
    Reginster JY, Denis D, Deroisy R, Lecart MP, De Longueville M, Zegels B, Sarlet N, Noirfalisse P, Franchimont P.
    J Bone Miner Res; 1994 Jan 16; 9(1):69-73. PubMed ID: 8154311
    [Abstract] [Full Text] [Related]

  • 40. Efficacy and harms of nasal calcitonin in improving bone density in young patients with inflammatory bowel disease: a randomized, placebo-controlled, double-blind trial.
    Pappa HM, Saslowsky TM, Filip-Dhima R, DiFabio D, Hassani Lahsinoui H, Akkad A, Grand RJ, Gordon CM.
    Am J Gastroenterol; 2011 Aug 16; 106(8):1527-43. PubMed ID: 21519359
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.